JP Stock MarketDetailed Quotes

5591 Avilen

Watchlist

911
+14+1.56%

20min DelayMarket Closed Dec 30 15:30 JST

5.56BMarket Cap49.19P/E (Static)

Avilen Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avilen Q3 2024 Earnings Date

Currency：JPYNov 14, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	325.00M	--
		+24.96%
EPS	--	6.09	--
		+49.19%

Analyst Rating

No Data

Avilen Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
Nov 14, 2024	2024/Q3	325.000M / --	--
May 15, 2024	2024/Q1	276.000M / --	--

DatePeriodRevenue/EstimateEarnings Call

Nov 14, 20242024/Q3325.000M / ----

May 15, 20242024/Q1276.000M / ----

--------

Unlock Free Earnings Estimates

Open Account

Avilen Earnings Reports

Avilen: Interim Report of Corrections

Nov 14, 2024 03:00 ET

Avilen: Presentation of financial results for the 3rd quarter of the fiscal year ending 2024/12

Nov 14, 2024 01:30 ET

Avilen: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

Nov 14, 2024 01:30 ET

Avilen: Interim report

Oct 30, 2024 02:00 ET

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.